QJM Advance Access originally published online on February 22, 2006
QJM 2006 99(3):197-198; doi:10.1093/qjmed/hcl022
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Correspondence |
Angioedema may not be a class side-effect of the angiotensin-converting-enzyme inhibitors
| The first 10% of the full text of this article appears below. |
Sir,
Angioedema is a well-documented and potentially life-threatening side-effect of treatment with angiotensin-converting-enzyme (ACE) inhibitors, occurring in 0.10.2% of patients treated with these drugs.1 Given the growing number of patients with hypertension or heart failure treated with these drugs, and the long duration of treatment, the frequency of
Second Propedeutic Department of Internal Medicine Medical School Aristotle University of Thessaloniki Hippokration Hospital Thessaloniki Greece
email: astkar@med.auth.gr